Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events. METHODS: We conducted a randomized trial involving 2287 patients who had objective evidence of myocardial ischemia and significant coronary artery disease at 50 U.S. and Canadian centers. Between 1999 and 2004, we assigned 1149 patients to undergo PCI with optimal medical therapy (PCI group) and 1138 to receive optimal medical therapy alone (medical-therapy group). The primary outcome was death from any cause and nonfatal myocardial infarction during a follow-up period of 2.5 to 7.0 years (median, 4.6). RESULTS: There were 211 primary events in the PCI group and 202 events in the medical-therapy group. The 4.6-year cumulative primary-event rates were 19.0% in the PCI group and 18.5% in the medical-therapy group (hazard ratio for the PCI group, 1.05; 95% confidence interval [CI], 0.87 to 1.27; P=0.62). There were no significant differences between the PCI group and the medical-therapy group in the composite of death, myocardial infarction, and stroke (20.0% vs. 19.5%; hazard ratio, 1.05; 95% CI, 0.87 to 1.27; P=0.62); hospitalization for acute coronary syndrome (12.4% vs. 11.8%; hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56); or myocardial infarction (13.2% vs. 12.3%; hazard ratio, 1.13; 95% CI, 0.89 to 1.43; P=0.33). CONCLUSIONS: As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy. (ClinicalTrials.gov number, NCT00007657 [ClinicalTrials.gov].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended (Fig. 10.5), in part because these high-risk people should already be receiving intensive medical therapy-an approach that provides benefits similar to those of invasive revascularization (208,209).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [208]
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended, in part because these high-risk people should already be receiving intensive medical therapy—an approach that provides benefits similar to those of invasive revascularization (197,198).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [197]
In the citing paper
“OMT with risk modification remains the foundation of management in patients with T2DM and CAD.263,264”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [264]
In the citing paper
“these high-risk patients should already be receiving intensive medical therapy -an approach that provides benefi t similar to invasive revascularization (172,173).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [172]
In the citing paper
“The screening of asymptomatic patients remains controversial, especially as intensive medical therapy indicated in diabetic patients at high risk for CVD has an increasing evidence base for providing equal outcomes to invasive revascularization, including in diabetic patients (222).”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [222]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Self-citationThe SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Keeley, E. C., Boura, J. A., & Grines, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12113-7 · Cited by 4,361
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Research works printed but not linked: 2
- 1994, Lancet, 344, 1383
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
Cited by
Items 501–600 of 1,002
Integración entre cardiología y atención primaria: impacto sobre la práctica clínica
Falces, C., Andrea, R., Heras, M., Vehí, C., Sorribes, M., Sanchís, L., Cevallos, J., Menacho, I., Porcar, S., Font, D. G., et al. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.02.021 · Cited by 83
Lateef, N., Khan, M. S., Deo, S. V., Yamani, N., Riaz, H., Virk, H. U. H., Khan, S. U., Hedrick, D. P., Kanaa’N, A., Reed, G. W., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.08.024 · Cited by 68
Reasonable Incomplete Revascularization
Dauerman, H. L. (2011) · Circulation · doi:10.1161/circulationaha.111.033126 · Cited by 67
Radiation Exposure From Medical Imaging in Patients With Chronic and Recurrent Conditions
Stein, E. G., Haramati, L. B., Bellin, E. Y., Ashton, L., Mitsopoulos, G., Schoenfeld, A. H., & Amis, E. S. (2010) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2009.12.015 · Cited by 66
Coronary Artery Disease and Risk of Major Vascular Events After Cerebral Infarction
Amarenco, P., Lavallée, P. C., Labreuche, J., Ducrocq, G., Juliard, J., Feldman, L. J., Cabrejo, L., Meseguer, E., Guidoux, C., Adraï, V., et al. (2013) · Stroke · doi:10.1161/strokeaha.111.000142 · Cited by 69
CMR First-Pass Perfusion for Suspected Inducible Myocardial Ischemia
Hendel, R. C., Friedrich, M. G., Schulz‐Menger, J., Zemmrich, C., Bengel, F. M., Berman, D. S., Camici, P. G., Flamm, S. D., Guludec, D. L., Kim, R., et al. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2016.09.010 · Cited by 66
Self-citationJCS Joint Working Group (2013) · Circulation Journal · doi:10.1253/circj.cj-66-0065 · Cited by 66
“[Level of Evidence: B] (5) Patients with contraindications to clopidogrel should be treated with ticlopidine (200 mg/day).”
BackgroundCardiovascular Disease in Women
Stock, E. O., & Redberg, R. (2012) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.07.001 · Cited by 65
Role of short-acting nitroglycerin in the management of ischemic heart disease
Sidhu, M. S., Boden, W. E., Padala, S. K., Cabral, K. P., & Buschmann, I. R. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s79116 · Cited by 87
Self-citationSk, G., Sawhney, R. C., Rai, L., Chavan, V., Dani, S., Arora, R. C., Selvamurthy, W., Chopra, H. K., & Nanda, N. C. (2011) · PubMed · Cited by 82
Bruthans, J., Cífková, R., Lánská, V., O’Flaherty, M., Critchley, J., Holub, J., Jánský, P., Zvárová, J., & Capewell, S. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312469476 · Cited by 66
Hannan, E. L., Zhong, Y., Walford, G., Holmes, D. R., Venditti, F. J., Berger, P. B., Jacobs, A. K., Stamato, N. J., Curtis, J. P., Sharma, S., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.074 · Cited by 64
Buschmann, E. E., Utz, W., Pagonas, N., Schulz‐Menger, J., Busjahn, A., Monti, J., Maerz, W., le Noble, F. A. C., Thierfelder, L., Dietz, R., et al. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02192.x · Cited by 64
McEvoy, J. W. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.204 · Cited by 65
“These concerns are highlighted by the findings of COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation), which showed that aggressive medical and lifestyle interventions led to similar outcomes compared with PCI in patients with stable CHD.(27) In such, we found that the evidence-free…”
ResultThom, H. H. Z., West, N. E. J., Hughes, V., Dyer, M., Buxton, M. J., Sharples, L. D., Jackson, C. H., Crean, A. M., & The CECaT study group (2014) · BMJ Open · doi:10.1136/bmjopen-2013-003419 · Cited by 65
Djerf, H., Millinger, J., Falkenberg, M., Jivegård, L., Svensson, M., & Nordanstig, J. (2020) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.119.008450 · Cited by 64
LeRoy, L., Bayliss, E., Domino, M., Miller, B. F., Rust, G., Gerteis, J., & Miller, T. (2014) · Medical Care · doi:10.1097/mlr.0000000000000095 · Cited by 64
“The COURAGE trial of interventions for coronary disease screened 35,539 patients with stable coronary artery disease and excluded 52% because of additional complicating conditions.(4) To whom, then, are the results generalizable? Further, what does the primary care clinician recommend for those patients who have coron…”
MethodMancini, G. B. J., Farkouh, M. E., Brooks, M. M., Chaitman, B. R., Boden, W. E., Vlachos, H., Hartigan, P. M., Siami, F. S., Sidhu, M. S., Bittner, V., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.021 · Cited by 64
Self-citationUeki, Y., Otsuka, T., Bär, S., Koskinas, K., Heg, D., Häner, J. D., Siontis, G. C. M., Praz, F., Hunziker, L., Lanz, J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.11.047 · Cited by 65
Subramanian, S., Sabik, J. F., Houghtaling, P. L., Nowicki, E. R., Blackstone, E. H., & Lytle, B. W. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.02.032 · Cited by 64
Arroyo‐Espliguero, R., y, P. A., Quiles, J., & Kaski, J. C. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.009 · Cited by 75
Kumar, S., Walters, T. E., Halloran, K., Morton, J. B., Hepworth, G., Wong, C. X. J., Kistler, P. M., Sanders, P., & Kalman, J. M. (2013) · EP Europace · doi:10.1093/europace/eut162 · Cited by 67
“Over the past decade, PCI has been demonstrated to be an efficacious treatment strategy in high-risk patients with acute coronary syndromes (with or without ST-segment elevation) providing significant reduction in death and myocardial infarction compared with a conservative strategy of medical therapy alone,12 prompti…”
BackgroundNakamura, M., Yamagishi, M., Ueno, T., Hara, K., Ishiwata, S., Itoh, T., Hamanaka, I., Wakatsuki, T., Sugano, T., Kawai, K., et al. (2014) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-014-0259-3 · Cited by 64
Management of stable angina: summary of NICE guidance: Figure 1
Henderson, R. A., & O’Flynn, N. (2012) · Heart · doi:10.1136/heartjnl-2011-301436 · Cited by 63
“6 years demonstrated no prognostic benefit from the percutaneous revascularisation strategy.(38) The BARI-2D trial randomised 2368 patients with type 2 diabetes and coronary artery disease to myocardial revascularisation combined with intensive medical treatment or to intensive medical treatment alone.”
BackgroundMethodUse of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry
Neglia, D., Liga, R., Gimelli, A., Podlesnikar, T., Cvijić, M., Pontone, G., Miglioranza, M. H., Guaricci, A. I., Seitun, S., Clemente, A., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac640 · Cited by 71
Current concepts in coronary artery revascularisation
Gaudino, M. F. L., Andreotti, F., & Kimura, T. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00459-2 · Cited by 81
Abidov, A. A., Gallagher, M. J., Chinnaiyan, K. M., Mehta, L. S., Wegner, J. H., & Raff, G. L. (2009) · Journal of Nuclear Cardiology · doi:10.1007/s12350-009-9117-6 · Cited by 63
KONES, R. J. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s11100 · Cited by 71
Schwartz, L., Bertolet, M., Feit, F., Fuentes, F., Sako, E. Y., Toosi, M. S., Davidson, C. J., Ikeno, F., & King, S. B. (2012) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.111.963512 · Cited by 63
Cardiac Resynchronization Therapy
Cleland, J. G. F., Tavazzi, L., Daubert, J., Abdellah, A. T., & Freemantle, N. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.040 · Cited by 63
Personalized treatment for coronary artery disease patients: a machine learning approach
Bertsimas, D., Orfanoudaki, A., & Weiner, R. B. (2020) · Health Care Management Science · doi:10.1007/s10729-020-09522-4 · Cited by 80
Mesnier, J., Ducrocq, G., Danchin, N., Ferrari, R., Ford, I., Tardif, J., Tendera, M., Fox, K. M., Steg, P. G., & for the CLARIFY Investigators (2021) · Circulation · doi:10.1161/circulationaha.121.054567 · Cited by 74
Adherence to Statin Therapy in Elderly Patients After Hospitalization for Coronary Revascularization
Kulik, A., Shrank, W. H., Levin, R., & Choudhry, N. K. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.01.013 · Cited by 64
Imaging of coronary atherosclerosis — evolution towards new treatment strategies
Dweck, M. R., Doris, M. K., Motwani, M., Adamson, P. D., Slomka, P. J., Dey, D., Fayad, Z. A., Newby, D. E., & Berman, D. S. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.79 · Cited by 71
Self-citationAppropriate Use Criteria for PET Myocardial Perfusion Imaging
Schindler, T. H., Bateman, T. M., Berman, D. S., Chareonthaitawee, P., Blanche, L. E. D., Dilsizian, V., Dorbala, S., Gropler, R. J., Shaw, L. J., Soman, P., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.246280 · Cited by 67
“By this time, if indicated, guideline-directed lifestyle and medical therapy would be expected to have been implemented (163), but disease progression may have occurred.”
BackgroundInfluentialSelf-citationFrattaroli, J., Weidner, G., Merritt-Worden, T. A., Frenda, S. J., & Ornish, D. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.039 · Cited by 66
The Anti-Ischemic Mechanism of Action of Ranolazine in Stable Ischemic Heart Disease
Stone, P. H., CHAITMAN, B. R., Stocke, K. S., Sano, J., DeVault, A. R., & Koch, G. G. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.042 · Cited by 61
Self-citationDiagnosis of Elderly Patients with Heart Failure
Manzano, L., Escobar, C., Cleland, J. G. F., & Flather, M. D. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs109 · Cited by 66
“Referral to exclude ischaemic heart disease, particularly when a patient does not exhibit angina, may not be useful as revascularization has not proved effective in patients with stable coronary disease and HF.(4,32,33) although patients with limiting angina should be referred for a specialist opinion.”
BackgroundInfluentialGehi, A. K. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.13.1423 · Cited by 61
Kumsārs, I., Narbute, I., Thuesen, L., Niemelä, M. J., Steigen, T. K., Kervinen, K., Sondore, D., Holm, N. R., Lassen, J. F., Christiansen, E. H., et al. (2012) · EuroIntervention · doi:10.4244/eijv7i10a186 · Cited by 61
Gadobutrol-Enhanced Cardiac Magnetic Resonance Imaging for Detection of Coronary Artery Disease
Arai, A. E., Schulz‐Menger, J., Berman, D. S., Mahrholdt, H., Han, Y., Bandettini, W. P., Gutberlet, M., Abraham, A., Woodard, P. K., Selvanayagam, J. B., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.060 · Cited by 61
Self-citationKarády, J., Mayrhofer, T., Ivanov, A. V., Foldyna, B., Lu, M. T., Ferencik, M., Pursnani, A. K., Salerno, M., Udelson, J. E., Mark, D. B., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.28312 · Cited by 69
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization
Kawashima, H., Serruys, P. W. J. C., Ono, M., Hara, H., O’Leary, N., Mack, M. J., Holmes, D. R., Morice, M., Head, S. J., Kappetein, A. P., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.087 · Cited by 65
Werner, G. S., Hildick‐Smith, D., Yuste, V. M., Boudou, N., Sianos, G., Gelev, V., Rumoroso, J. R., Ērglis, A., Christiansen, E. H., Escaned, J., et al. (2023) · EuroIntervention · doi:10.4244/eij-d-23-00312 · Cited by 60
Teo, K. K., Sedlis, S. P., Boden, W. E., O’Rourke, R. A., Maron, D. J., Hartigan, P. M., Dada, M. R., Gupta, V., Spertus, J. A., Kostuk, W. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.013 · Cited by 60
“Demographic Sex: male 599 (87) 598 (86) Race: white 593 (86) 590 (85) Age (yrs) 55 6 56 6 Risk factor Current smoker 223 (32) 220 (32) Diabetic patient 216 (31) 240 (35) Hypertension 435 (63) 449 (65) Family history of CAD 396 (58) 370 (53) Cardiac history MI 278 (40) 272 (39) PCI 101 (15) 113 (16) CABG 54 (8) 57 (8)…”
Self-citationBangalore, S., Kumar, S., Volodarskiy, A., & Messerli, F. H. (2012) · Heart · doi:10.1136/heartjnl-2012-301968 · Cited by 66
Fox, K. A. A., Després, J., Richard, A., Brette, S., & Deanfield, J. E. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp371 · Cited by 60
“change.(30) However, thus far, initiatives in the broader medical community and in populations have been less successful.”
BackgroundInstitute for Clinical and Economic Review
Peter J., N., Joshua T., C., & Daniel A, O. (2021) · The Right Price · doi:10.1093/oso/9780197512883.003.0006 · Cited by 60
Qaseem, A., Fihn, S. D., Dallas, P., Williams, S., Owens, D. K., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-10-201211200-00011 · Cited by 60
Identifying the Vulnerable Patient with Rupture-Prone Plaque
WEINTRAUB, H. S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.013 · Cited by 65
Lang, C. C., Gupta, S., Kalra, P. R., Keavney, B. D., Menown, I. B. A., Morley, C., & Padmanabhan, S. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.029 · Cited by 66
König, A., Margolis, M. P., Virmani, R., Holmes, D. R., & Klauß, V. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1123 · Cited by 62
“Ongoing clinical studies could, however, demonstrate the efficacy of optimum medical therapy to prevent coronary intervention in patients with stable coronary artery disease”
BackgroundA Call to Action: Variability in Guidelines for Cardiac Evaluation before Renal Transplantation
Friedman, S. E., Palac, R. T., Zlotnick, D. M., Chobanian, M., & Costa, S. P. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09391010 · Cited by 63
“Although the ACC/ AHA guideline would have “missed” some of the patients with single vessel CAD, the benefit of PCI beyond medical therapy in these patients is not clear (12).”
MethodLau, A. Z., Miller, J. J. J. J., Robson, M. D., & Tyler, D. J. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26106 · Cited by 59
“Clinical evidence shows that revascularization only results in improved outcomes if targeted to the presence of significant myocardial ischemia (2,26,27).”
BackgroundAssessing quality-of-life outcomes in cardiovascular clinical research
Mark, D. B. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.10 · Cited by 68
Reperfusion strategies in acute myocardial infarction and multivessel disease
Vogel, B., Mehta, S. R., & Mehran, R. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.88 · Cited by 60
PREPARED Study: A Study of Shared Decision-Making for Coronary Artery Disease
Doll, J. A., Jones, W. S., Lokhnygina, Y. V., Culpepper, S., Parks, R. L., Calhoun, C., Au, D. H., & Patel, M. R. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005244 · Cited by 58
Bodı́, V., Sanchis, J. M., López-Lereu, M. P., Nunez, J., Mainar, L., Monmeneu, J. V., Ruiz, V., Rúmiz, E., Hüsser, O., Moratal, D., et al. (2008) · Heart · doi:10.1136/hrt.2007.139683 · Cited by 59
Percutaneous Coronary Intervention Use in the United States
Marso, S. P., Teirstein, P. S., Kereiakes, D. J., Moses, J. W., Lasala, J. M., & Grantham, J. A. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2011.12.004 · Cited by 58
Cordero, A., Galve, E., Bertoméu, V., Bueno, H., Fácila, L., Alegría, E., Cequier, A. R., Ruiz, E., & González‐Juanatey, J. R. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.08.010 · Cited by 60
Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease
Marcos‐Garcés, V., Gavara, J., Monmeneu, J. V., López-Lereu, M. P., Bosch, M. J., Merlos, P., Perez, N., Ríos‐Navarro, C., de Dios, E., Bonanad, C., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.02.027 · Cited by 59
Thomas, S., Gokhale, R., Boden, W. E., & Devereaux, P. J. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.07.010 · Cited by 58
Self-citationImplementation of Shared Decision Making in Cardiovascular Care: Past, Present, and Future
Hess, E. P., Coylewright, M., Frosch, D. L., & Shah, N. D. (2014) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000351 · Cited by 58
Laukkanen, J. A., Mäkikallio, T. H., Rauramaa, R., & Kurl, S. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn584 · Cited by 63
Cole, J., Htun, N., Lew, R., Freilich, M. I., Quinn, S. J., & Layland, J. J. (2021) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.009992 · Cited by 61
Physical activity and structured exercise for patients with stable ischemic heart disease
Boden, W. E., Franklin, B. A., & Wenger, N. K. (2013) · JAMA · doi:10.1001/jama.2012.128367 · Cited by 57
Self-citationKaneko, H., Yajima, J., Oikawa, Y., Tanaka, S., Fukamachi, D., Suzuki, S. S., Sagara, K., Otsuka, T., Matsuno, S., Funada, R., et al. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.02.009 · Cited by 57
Serial Myocardial Perfusion Imaging
Iskandrian, A. E., Hage, F. G., Shaw, L. J., Mahmarian, J. J., & Berman, D. S. (2014) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.05.022 · Cited by 56
Self-citationThe treatment of coronary artery disease—current status six decades after the first bypass operation
Doenst, T., Thiele, H., Haasenritter, J., Wahlers, T., Maßberg, S., & Haverich, A. (2022) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2022.0277 · Cited by 121
Ferrari, R., Ford, I., Fox, K., Steg, P. G., & Tendera, M. (2007) · Cardiology · doi:10.1159/000112412 · Cited by 65
Moroi, M., Yamashina, A., Tsukamoto, K., & Nishimura, T. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.01.040 · Cited by 57
“This is consistent with the results of the prospective COURAGE trial in which angiography was employed to select patients [4].”
BackgroundResultGaemperli, O., Saraste, A., & Knuuti, J. M. (2011) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ejechocard/jer240 · Cited by 59
Kovacic, J. C., Lee, P. C., Baber, U., Karajgikar, R., Evrard, S., Moreno, P., Mehran, R., Fuster, V., Dangas, G., Sharma, S. K., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.020 · Cited by 59
Choi, E.-K., Chun, E. J., Choi, S.-I., Chang, S.-A., Choi, S.-H., Lim, S., Rivera, J. J., Nasir, K., Blumenthal, R. S., Jang, H.-C., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.05.026 · Cited by 57
Rigattieri, S., Biondi‐Zoccai, G., Silvestri, P., Russo, C. D., Musto, C., Ferraiuolo, G., & Loschiavo, P. (2007) · Journal of Interventional Cardiology · doi:10.1111/j.1540-8183.2007.00317.x · Cited by 57
Jeremias, A., & Kirtane, A. J. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-3-200802050-00199 · Cited by 57
Fractional Flow Assessment for the Evaluation of Intracranial Atherosclerosis: A Feasibility Study
Miao, Z., Liebeskind, D. S., Lo, W.-T., Liu, L., Pu, Y., Leng, X., Song, L., Xu, X., Jia, B., Gao, F., et al. (2016) · Interventional Neurology · doi:10.1159/000444333 · Cited by 57
Low‐Value Service Use in Provider Organizations
Schwartz, A. L., Zaslavsky, A. M., Landon, B. E., Chernew, M. E., & McWilliams, J. M. (2016) · Health Services Research · doi:10.1111/1475-6773.12597 · Cited by 63
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial
Maron, D. J., Mancini, G. B. J., Hartigan, P. M., Spertus, J. A., Sedlis, S. P., Kostuk, W. J., Berman, D. S., Teo, K. K., Weintraub, W. S., & Boden, W. E. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2163 · Cited by 62
“25 Heart failure 5 (5) 12 (3) 21 (3) 31 (5) 13 (4) 2 (3) 0.”
BackgroundMethodSelf-citationThe Economics of public health care reform in advanced and emerging economies
Coady, D., Clements, B. J., & Gupta, S. (2013) · Choice Reviews Online · doi:10.5860/choice.50-2774 · Cited by 60
Hannan, E. L., Racz, M. J., Holmes, D. R., Walford, G. D., Sharma, S., Katz, S., Jones, R. H., & King, S. B. (2008) · Circulation · doi:10.1161/circulationaha.107.725531 · Cited by 56
Farzaneh‐Far, A., Phillips, H. R., Shaw, L. K., Starr, A. Z., Fiuzat, M., O’Connor, C. M., Sastry, A., Shaw, L. J., & Borges‐Neto, S. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.01.019 · Cited by 56
Self-citationCortigiani, L., Rigo, F., Gherardi, S., Bovenzi, F., Picano, E., & Sicari, R. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.08.669 · Cited by 56
KONES, R. J. (2010) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944710391350 · Cited by 60
Aghaebrahim, A., Jovin, T. G., Jadhav, A. P., Noorian, A., Gupta, R. G., & Nogueira, R. G. (2013) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2013-010842 · Cited by 56
“15 16 Our patient population, however, was pathophysiologically equivalent to patients with unstable angina where stent revascularization has clearly demonstrated a bene fi t.”
ResultAppropriateness of Percutaneous Coronary Interventions in Washington State
Bradley, S. M., Maynard, C. C., & Bryson, C. L. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.964320 · Cited by 56
“Furthermore, when PCI is used as an initial strategy for treatment of stable ischemic heart disease, the incremental relief of angina and improvement in quality of life is small, temporary, and not cost-effective.(4,6,7) Given the limited utility of PCI in nonacute settings, a rapid expansion in the use of PCI in the…”
BackgroundMethodImproving Terminology to Describe Coronary Artery Procedures
Doenst, T., Bonow, R. O., Bhatt, D. L., Falk, V., & Gaudino, M. F. L. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.010 · Cited by 59
Kodama, T., Kondo, T., Oida, A., Fujimoto, S., & Narula, J. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.02.016 · Cited by 55
Maron, D. J., Boden, W. E., Spertus, J. A., Hartigan, P. M., Mancini, G. B. J., Sedlis, S. P., Kostuk, W. J., CHAITMAN, B. R., Shaw, L. J., Berman, D. S., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.046 · Cited by 54
Self-citationValente, S., Lazzeri, C., Chiostri, M., Giglioli, C., Sori, A., Tigli, S., & Gensini, G. F. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.045 · Cited by 55
Teo, K. K., Cohen, E. A., Buller, C. E. H., Hassan, A., Carere, R. G., Cox, J. L., Ly, H. Q., Fedak, P. W. M., Chan, K. L., Légaré, J., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.034 · Cited by 58
Self-citationDiagnosing coronary artery disease with hybrid PET/CT: It takes two to tango
Danad, I., Raijmakers, P. G. H. M., & Knaapen, P. (2013) · Journal of Nuclear Cardiology · doi:10.1007/s12350-013-9753-8 · Cited by 55
“, \10% of the myocardium) does not alter outcome, yet alleviate symptoms.(114,115) Satisfactory medically controlled anginal symptoms therefore justify a conservative approach, and a potential hazardous invasive procedure should be deferred.”
Potential Applications of PET/MR Imaging in Cardiology
Ratib, O. M., & Nkoulou, R. N. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.129262 · Cited by 55
Chandrasekharan, D. P., & Taggart, D. P. (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.08.033 · Cited by 55
“It has been postulated that the survival benefit of CABG over PCI is because placing bypass grafts to the mid-coronary vessel not only treats the ‘culprit’ lesion — usually located in the proximal coronary artery(ies) — but also offers prophylaxis against the development of new proximal disease [2].”
BackgroundSánchez-Gracián, C. D., Pernas, R. O., López, C. T., Armentia, E. S., Liste, A. V., Caamaño, M. V., & de la Fuente, G. T. (2015) · European Radiology · doi:10.1007/s00330-015-4128-y · Cited by 55
Clerc, O. F., Fuchs, T. A., Stehli, J., Benz, D. C., Gräni, C., Messerli, M., Giannopoulos, A. A., Buechel, R. R., Lüscher, T. F., Pazhenkottil, A. P., et al. (2018) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jey014 · Cited by 56
“However, with the exception of EET, all CAD imaging tests have demonstrated uniformly a very high sensitivity and specificity for detecting CAD.40 Moreover, all non-invasive tests predict cardiac events based on the severity of their findings, also in patients with diabetes.8,11,14,15 Furthermore, the extent of diseas…”
BackgroundInfluentialKommi, D. N., Kumar, D., & Chakraborti, A. K. (2013) · Green Chemistry · doi:10.1039/c3gc36997h · Cited by 56
Anselmi, C. V., Briguori, C., Roncarati, R., Papa, L., Visconti, G., Focaccio, A., Micco, F. D., Latronico, M. V. G., Pagnotta, P. A., & Condorelli, G. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.06.010 · Cited by 56
KONES, R. J. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s7564 · Cited by 58
“However, women with chronic stable angina and CAD most certainly benefit from, and deserve, full medical therapy just as do men, 193 and the guidelines are clear.”
Metadata
- Authors
- Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G. B. J., & Weintraub, W. S.
- Affiliations
- VA Western New York Healthcare System (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-12
- Volume
- 356
- Issue
- 15
- Pages
- 1503-1516
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2160414137
- Cited by
- 4,699
- References
- 49
- Citations by year
- 2026: 111 · 2025: 142 · 2024: 150 · 2023: 166 · 2022: 197 · 2021: 255 · 2020: 282 · 2019: 202 · 2018: 227 · 2017: 211 · 2016: 276 · 2015: 263 · 2014: 295 · 2013: 309 · 2012: 322
- FWCI
- 315.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- optimal medical therapy, percutaneous coronary intervention, stable coronary artery disease, myocardial ischemia, cardiovascular events, myocardial infarction, mortality, lifestyle intervention, coronary artery disease
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angina Pectoris, Angiotensin-Converting Enzyme Inhibitors, Anticholesteremic Agents, Antihypertensive Agents, Combined Modality Therapy, Coronary Disease, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Risk Factors, Angioplasty, Balloon, Coronary, Proportional Hazards Models, Stroke, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.